» Articles » PMID: 15693727

Measuring Productivity Changes in Economic Evaluation: Setting the Research Agenda

Overview
Specialty Pharmacology
Date 2005 Feb 8
PMID 15693727
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Productivity costs related to illness may be relevant in assessing healthcare programmes for patients, as well as occupational interventions for workers. When performing an economic evaluation for both types of programmes, a sound methodology for measuring and valuing these productivity costs is essential. This article reviews research questions related to productivity and health, focusing on the costs of short-term absence from work, productivity costs without absence ('presenteeism') and possible compensation mechanisms and circumstances that may affect productivity costs. Furthermore, the important but under-explored relationship between productivity and QOL is analysed. Strategies for better answers on these research questions, such as developing more valid measurement instruments, are discussed. It is stressed that the analysis of productivity costs should not be restricted to the level of the individual patient and worker but extended to the level of teams of workers and firms. It may be advisable to explore several issues such as compensation mechanisms and efficiency losses in detail using employee questionnaires and consecutively applying the key elements in patient settings. It seems advisable to develop flexible, modular instruments for measuring and valuing absence from work, compensation mechanisms, efficiency loss and details of jobs and organisation in an integrative and consistent way. Further, it seems crucial to identify what determinants of jobs and organisations are the key factors in estimating productivity costs. This list of determinants could be mapped with a classification of jobs, to be used as a screener in patient questionnaires.

Citing Articles

The physical activity paradox in relation to work ability and health-related productivity loss in Korea.

Ko H, Kim D, Cho S, Kang M Epidemiol Health. 2023; 45:e2023096.

PMID: 37946413 PMC: 10876421. DOI: 10.4178/epih.e2023096.


The Norwegian version of the Copenhagen Psychosocial Questionnaire (COPSOQ III): Initial validation study using a national sample of registered nurses.

Ose S, Lohmann-Lafrenz S, Bernstrom V, Berthelsen H, Marchand G PLoS One. 2023; 18(8):e0289739.

PMID: 37616307 PMC: 10449149. DOI: 10.1371/journal.pone.0289739.


Multiplier Effects and Compensation Mechanisms for Inclusion in Health Economic Evaluation: A Systematic Review.

Krol M, Hosseinnia N, Brouwer W, van Roijen L Pharmacoeconomics. 2023; 41(9):1031-1050.

PMID: 37592122 PMC: 10450000. DOI: 10.1007/s40273-023-01304-4.


A general framework for selecting work participation outcomes in intervention studies among persons with health problems: a concept paper.

Ravinskaya M, Verbeek J, Langendam M, Madan I, Verstappen S, Kunz R BMC Public Health. 2022; 22(1):2189.

PMID: 36435773 PMC: 9701431. DOI: 10.1186/s12889-022-14564-0.


Incorporating productivity loss in health economic evaluations: a review of guidelines and practices worldwide for research agenda in China.

Jiang S, Wang Y, Si L, Zang X, Gu Y, Jiang Y BMJ Glob Health. 2022; 7(8).

PMID: 35977755 PMC: 9389102. DOI: 10.1136/bmjgh-2022-009777.


References
1.
Brouwer W, van Exel N, Koopmanschap M, Rutten F . Productivity costs before and after absence from work: as important as common?. Health Policy. 2002; 61(2):173-87. DOI: 10.1016/s0168-8510(01)00233-0. View

2.
Hagberg M, Tornqvist E, Toomingas A . Self-reported reduced productivity due to musculoskeletal symptoms: associations with workplace and individual factors among white-collar computer users. J Occup Rehabil. 2002; 12(3):151-62. DOI: 10.1023/a:1016890527520. View

3.
Brouwer W, Koopmanschap M . How to calculate indirect costs in economic evaluations. Pharmacoeconomics. 1998; 13(5 Pt 1):563-9. DOI: 10.2165/00019053-199813050-00008. View

4.
Lerner D, Amick 3rd B, Rogers W, Malspeis S, Bungay K, Cynn D . The Work Limitations Questionnaire. Med Care. 2001; 39(1):72-85. DOI: 10.1097/00005650-200101000-00009. View

5.
Severens J, Laheij R, Jansen J, Van der Lisdonk E, Verbeek A . Estimating the cost of lost productivity in dyspepsia. Aliment Pharmacol Ther. 1998; 12(9):919-23. DOI: 10.1046/j.1365-2036.1998.00376.x. View